Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Carcinoma, Renal Cell × Fluorescence × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 1

Interventions

pembrolizumab 47 Nivolumab 34 Sunitinib 18 Everolimus 17 Cyclophosphamide 17 Ipilimumab 15 cabozantinib 14 pazopanib 13 Bevacizumab 13 fludarabine 11 atezolizumab 11 temsirolimus 10 Magnetic Resonance Spectroscopy 10 Sorafenib 9 aldesleukin 8 Specimen Handling 8 Paclitaxel 8 Sirolimus 7 CTLA-4 Antigen 7 Axitinib 7 belzutifan 6 Radiosurgery 6 Oxaliplatin 6 Interleukin-2 6 Fluorouracil 6 spartalizumab 5 avelumab 5 Leucovorin 5 Irinotecan 5 Docetaxel 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02497599 2021-09-29

Intraoperative Dual-modality Imaging in Renal Cell Carcinoma

Radboud University Medical Center

Phase 1 Unknown

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡